Top CRO M&A activity of 2016

Top CRO M&A activity of 2016

As 2016 comes to a close, Outsourcing-Pharma.com looks back at some of the major mergers and acquisitions from the past year.

Related News

(Image: iStock/Tsyhun)

Pharmaron acquires Xceleron as it looks to provide 'end-to-end' services

Pharmaron acquires clinical CRO SNBL CPC

Pharmaron acquires clinical CRO

Integrated Development Associates Co. Ltd. (IDA) specializes in integrating Japan and Asia into global drug development. (Image: iStock/Kritchanut)

Chiltern acquires Japanese CRO

Rich Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies in oncology. (Image: iStock/bedo)

Rich Pharmaceuticals selects clinical site, CRO for Ph I/II trial

(Image: iStock/shironosov)

How CROs and foundations are partnering to advance drug discovery and development

Related Products

See more related products